Single-Cut Gene Editing Therapy for Duchenne Muscular Dystrophy via a Single AAV Vector

被引：0
|
作者：
Li, Guoling [1 ]
Lin, Jiajia [2 ]
Li, Haisen [1 ]
Jin, Ming [2 ]
Li, Zhifang [3 ]
Shi, Linyu [1 ]
Wang, Ning [2 ]
Chen, Wanjin [2 ]
Yang, Hui [1 ,4 ]
机构：
[1] HuidaGene Therapeut Co Ltd, Shanghai, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp 1, Dept Neurol, Fuzhou, Peoples R China
[3] Lingang Lab, Shanghai, Peoples R China
[4] Chinese Acad Sci, Ctr Excellence Brain Sci & Intelligence Technol, Shanghai, Peoples R China
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
951
引用
收藏
页码：461 / 462
页数：2
相关论文
共 50 条
  • [41] An alternative to gene therapy for Duchenne muscular dystrophy?
    Butcher, J
    LANCET NEUROLOGY, 2003, 2 (01): : 7 - 7
  • [42] The FDA and Gene Therapy for Duchenne Muscular Dystrophy
    Rind, David M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (20): : 1705 - 1706
  • [43] Advances in Duchenne muscular dystrophy gene therapy
    van Deutekom, JCT
    van Ommen, GJB
    NATURE REVIEWS GENETICS, 2003, 4 (10) : 774 - 783
  • [44] AAV gene therapy for Duchenne Muscular Dystrophy: lessons learned from a phase 3 trial
    Baranello, Giovanni
    Muntoni, Francesco
    GENE THERAPY, 2024, 31 (11-12) : 541 - 543
  • [45] Assessment of systemic AAV-microdystrophin gene therapy in the GRMD model of Duchenne muscular dystrophy
    Birch, Sharla M.
    Lawlor, Michael W.
    Conlon, Thomas J.
    Guo, Lee-Jae
    Crudele, Julie M.
    Hawkins, Eleanor C.
    Nghiem, Peter P.
    Ahn, Mihye
    Meng, Hui
    Beatka, Margaret J.
    Fickau, Brittany A.
    Prieto, Juan C.
    Styner, Martin A.
    Struharik, Michael J.
    Shanks, Courtney
    Brown, Kristy J.
    Golebiowski, Diane
    Bettis, Amanda K.
    Balog-Alvarez, Cynthia J.
    Clement, Nathalie
    Coleman, Kirsten E.
    Corti, Manuela
    Pan, Xiufang
    Hauschka, Stephen D.
    Gonzalez, J. Patrick
    Morris, Carl A.
    Schneider, Joel S.
    Duan, Dongsheng
    Chamberlain, Jeffrey S.
    Byrne, Barry J.
    Kornegay, Joe. N.
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (677)
  • [46] Impact of myofiber centronucleation on AAV therapy efficiency for Duchenne muscular dystrophy
    Mollard, A.
    Peccate, C.
    Julien, L.
    Marais, T.
    Pietri-Rouxel, F.
    Benkhelifa-Ziyyat, S.
    Lorain, S.
    HUMAN GENE THERAPY, 2016, 27 (11) : A152 - A152
  • [47] Enhanced Dystrophin Gene Editing and Cas9 Inactivation via AAV Re-Administration in a Mouse Model of Duchenne Muscular Dystrophy
    Bengtsson, Niclas E.
    Chamberlain, Jeffrey S.
    MOLECULAR THERAPY, 2022, 30 (04) : 269 - 270
  • [48] Full-dsytrophin packaging in lentiviral vector for a gene therapy of duchenne muscular dystrophy
    Kimura, En
    Uchino, Katsuhisa
    Suga, Tomohiro
    Ishizaki, Masatoshi
    Koide, Tatsuya
    Maeda, Yasushi
    Uchino, Makoto
    HUMAN GENE THERAPY, 2009, 20 (11) : 1497 - 1497
  • [49] Preclinical Development of MyoDys45-55, a Gene Editing Therapy for Duchenne Muscular Dystrophy
    Dorst, William
    Gibbs, Elizabeth
    Nguyen, Jonathan
    Perez, Jesus
    Hagerty, Laura
    Emami, Michael R.
    Bengtsson, Niclas E.
    Chamberlain, Jeffrey S.
    Pyle, April D.
    Spencer, Melissa J.
    Young, Courtney S.
    MOLECULAR THERAPY, 2023, 31 (04) : 332 - 332
  • [50] Development of gene editing approaches for the treatment of Duchenne muscular dystrophy (DMD)
    Moore, M.
    Vallese, D.
    Kymalainen, H.
    Dickson, G.
    Popplewell, L.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S15 - S15
12345